appengine.ai

Artificial Intelligence | Machine Learning | Machine Perception Immunai | Decoding the Immune System to Improve Health


Consumer, Immunology, Healthcare, Biotechnology, Genomic Technologies New York, NY, United States

Immunai

Artificial Intelligence | Machine Learning | Machine Perception


Immunai | Decoding the Immune System to Improve Health

Immunai

Immunology, Healthcare, Biotechnology, Genomic Technologies


New York, NY, United States

Comprehensively mapping the immune system with single-cell biology and AI to power new therapeutic discoveries, accelerate drug development and improve patient outcomes

Immunai’s end-to-end single-cell platform enables high resolution profiling of the immune system at industrial scale, generating biological insights that accelerate R&D and power novel discoveries

 

B2C, B2B

26 to 50

Seed

$20,000,000

Launched

2019

 
 

Healthcare
Health Care Facilities & Hospitals
Biotechnology

Decoding the Immune System to Improve Health

N/A

 
 

Analytics
Service

Yes

Active

 
 

   Machine Learning
   Machine Perception
   Natural Language Processing


Immunai?s immune Profiling Platform

Immunai?s immune Profiling Platform


N/A

 

   Software


NA

NA


NA

NA

 
 
Noam Solomon


Noam Solomon
CEO

Daniel Wells


Daniel Wells
Co-Founder